行情

ATNM

ATNM

Actinium Pharmac
AMEX
11.11
+0.11
+0.95%
交易中 10:17 11/28 EST
开盘
11.10
昨收
11.00
最高
11.24
最低
10.82
成交量
2.53万
成交额
13.09万
52周最高
15.12
52周最低
4.410
市值
2.83亿
市盈率(TTM)
-8.5555
分时
5日
1月
3月
1年
5年
更新:Actinium Pharmaceuticals 从靶向放疗候选者的 3 期试验中获得了积极的一线结果;股价上涨
更新:Actinium Pharmaceuticals 从靶向放疗候选者的 3 期试验中获得了积极的一线结果;股价上涨
MT Newswires · 10/31 12:48
--HC Wainwright 将 Actinium Pharmaceuticals 的目标价从 45 美元调整至 53 美元,维持买入评级
--HC Wainwright 将 Actinium Pharmaceuticals 的目标价从 45 美元调整至 53 美元,维持买入评级
MT Newswires · 10/31 10:24
--B。在对 Iomab-B 的 SIERRA 3 期试验进行积极更新后,Riley 将 Actinium Pharmaceuticals 的 PT 从 16 美元提高到 18 美元,保持买入评级
--B。在对 Iomab-B 的 SIERRA 3 期试验进行积极更新后,Riley 将 Actinium Pharmaceuticals 的 PT 从 16 美元提高到 18 美元,保持买入评级
MT Newswires · 10/31 07:55
Actinium Pharmaceuticals 从靶向放射治疗候选药物的 3 期试验中获得积极的一线结果
Actinium Pharmaceuticals 从靶向放射治疗候选药物的 3 期试验中获得积极的一线结果
MT Newswires · 10/31 07:05
Cantor Fitzgerald 以 20 美元的价格目标超重启动 Actinium Pharmaceuticals
Cantor Fitzgerald 以 20 美元的价格目标超重启动 Actinium Pharmaceuticals
MT Newswires · 09/08 09:19
ATNM 简况
Actinium Pharmaceuticals, Inc. is a clinical-stage, biopharmaceutical company. The Company is focused on developing and commercializing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs. Its clinical programs use its Antibody Warhead Enabling (AWE) technology platform. Its clinical pipeline is led by Antibody Radiation-Conjugates (ARCs). Its lead product candidate, Iomab-B (I-131 apamistamab), is a targeted conditioning agent, which consists of an anti-CD45 monoclonal antibody and the radioisotope Iodine-131 (I-131). Its clinical and preclinical development programs utilize multiple isotopes, including Actinium-225, Iodine-131 and Lutetium-177 directed at multiple validated cancer targets, including CD45, CD33, CD38, CD47, HER2 and HER3 for targeted conditioning prior to cell and gene therapies, including bone marrow transplant (BMT) and cancer therapeutics in combination with other therapeutic modalities.

微牛提供Actinium Pharmaceuticals Inc(AMEX-ATNM)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ATNM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ATNM股票基本功能。